RADX - Radiopharm Theranostics • Financials

Radiopharm Theranostics Ltd is an Australian-based clinical-stage radiotherapeutics company targeting cancer. The company has a pipeline of approximately four licensed platform technologies, with diagnostic and therapeutic applications at both the pre-clinical and clinical stages of development. The company is engaged in research, development, and commercialization of health technologies.

Complete and updated financials table with all primary indicators: Net Income, Revenue, EBITDA, Margin, ROE, Dividends

Year	Revenue	EBITDA	Net Inc	Net Mrg	EPS	Equity	ROE	Net Debt Aj	ND/EBITDA Aj	OCF Aj	Capex	FCF	Free Aj	Buyback	Dividend	Payout	DY
06/2022	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
06/2023	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
06/2024	0	-29	-	L	L	19	L	-8	-	-17	0	20	-17	0	0	-	-
06/2025	2	-23	-	L	L	29	L	-17	-	-25	0	30	-25	0	0	-	-
06/2026	2	-39	-	L	L	17	L	-3	-	-36	0	23	-36	0	0	-	-

To see all financials—including updated, you must be Premium.